MA06.04 KRYSTAL-1: Two-Year Follow-Up of Adagrasib (MRTX849) Monotherapy in Patients with Advanced/Metastatic KRASG12C-Mutated NSCLC

Shirish M. Gadgeel, Pasi A. Jänne, Alexander I. Spira, S.‐H.I. Ou, Rebecca S. Heist, J.M. Pacheco, M.L. Johnson, Joshua K. Sabari, Konstantinos Leventakos, J.A. Mason, Karen Velastegui, Xiaohong Yan, Richard C. Chao, Gregory J. Riely